GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cipher Pharmaceuticals Inc (TSX:CPH) » Definitions » Operating Cash Flow per Share

Cipher Pharmaceuticals (TSX:CPH) Operating Cash Flow per Share : C$0.85 (TTM As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Cipher Pharmaceuticals Operating Cash Flow per Share?

Cipher Pharmaceuticals's operating cash flow per share for the three months ended in Dec. 2023 was C$0.13. Cipher Pharmaceuticals's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.85.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Cipher Pharmaceuticals was 49.40% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 15.60% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 9.00% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 2.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Cipher Pharmaceuticals's Operating Cash Flow per Share or its related term are showing as below:

TSX:CPH' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -21.5   Med: 11.6   Max: 77.3
Current: 15.6

During the past 13 years, Cipher Pharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 77.30% per year. The lowest was -21.50% per year. And the median was 11.60% per year.

TSX:CPH's 3-Year OCF Growth Rate is ranked better than
60.79% of 806 companies
in the Drug Manufacturers industry
Industry Median: 8.1 vs TSX:CPH: 15.60

Cipher Pharmaceuticals Operating Cash Flow per Share Historical Data

The historical data trend for Cipher Pharmaceuticals's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cipher Pharmaceuticals Operating Cash Flow per Share Chart

Cipher Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Cash Flow per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.43 0.55 0.66 0.57 0.84

Cipher Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.25 0.15 0.31 0.13

Competitive Comparison of Cipher Pharmaceuticals's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Cipher Pharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cipher Pharmaceuticals's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cipher Pharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Cipher Pharmaceuticals's Price-to-Operating-Cash-Flow falls into.



Cipher Pharmaceuticals Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Cipher Pharmaceuticals's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )=Cash Flow from Operations (A: Dec. 2023 )/Shares Outstanding (Diluted Average) (A: Dec. 2023 )
=21.464/25.422
=0.84

Cipher Pharmaceuticals's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )=Cash Flow from Operations (Q: Dec. 2023 )/Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
=3.241/24.778
=0.13

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cipher Pharmaceuticals Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Cipher Pharmaceuticals's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Cipher Pharmaceuticals (TSX:CPH) Business Description

Traded in Other Exchanges
Address
5750 Explorer Drive, Suite 404, Mississauga, ON, CAN, L4W 0A9
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, specialty medicines, and Out-Licensed Products among others. The company's geographical operational areas include Canada and the United States.

Cipher Pharmaceuticals (TSX:CPH) Headlines

No Headlines